NFKB1 and metabolic dysfunction-associated steatohepatitis: [25] Farrell and colleagues describe nuclear factor-kappa B (NF-κB) and c-Jun N-terminal kinase (JNK) as the key proinflammatory signal molecules increased in NASH, as these signaling pathways provide a link between hepatic inflammation and insulin resistance.